Literature DB >> 2241118

Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis.

L A Lampson1, P D Kushner, R A Sobel.   

Abstract

Monoclonal antibody immunocytochemistry was used to examine spinal cord and muscle in amyotrophic lateral sclerosis for changes that would indicate ongoing or potential immune activity. Increased expression of class I and II major histocompatibility complex (MHC) antigens was seen in the affected areas of spinal cord. New MHC expression was concentrated in phagocytes, particularly in degenerating white matter in which they were dispersed in the tissue and also packed around blood vessels. MHC antigen was not revealed in motor neurons or skeletal muscle fibers. An anti-pan-T-cell monoclonal revealed small numbers of T cells in degenerating white matter. Similar changes have been seen in other neurodegenerative disorders. They suggest a potential for (secondary) cell-mediated activity in the affected areas rather than an ongoing MHC-restricted T-cell response. Vessel-associated phagocytes may be a source of antigen to peripheral lymphoid tissue, stimulating production of the autoantibodies that have been described.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2241118     DOI: 10.1002/ana.410280311

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

1.  Amyotrophic Lateral Sclerosis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-01       Impact factor: 3.598

2.  ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity.

Authors:  David R Beers; Weihua Zhao; Jinghong Wang; Xiujun Zhang; Shixiang Wen; Dan Neal; Jason R Thonhoff; Abdullah S Alsuliman; Elizabeth J Shpall; Katy Rezvani; Stanley H Appel
Journal:  JCI Insight       Date:  2017-03-09

Review 3.  Immunological findings in amyotrophic lateral sclerosis.

Authors:  J P Antel; N R Cashman
Journal:  Springer Semin Immunopathol       Date:  1995

Review 4.  Motor neuron-immune interactions: the vicious circle of ALS.

Authors:  Ana G Barbeito; Pinar Mesci; Séverine Boillée
Journal:  J Neural Transm (Vienna)       Date:  2010-06-15       Impact factor: 3.575

5.  Inflammatory cells in the peripheral nervous system in motor neuron disease.

Authors:  H Kerkhoff; D Troost; E S Louwerse; M van Dijk; H Veldman; F G Jennekens
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Expression and localization of prostaglandin transporter in Alzheimer disease brains and age-matched controls.

Authors:  Koyi Choi; Hean Zhuang; Barbara Crain; Sylvain Doré
Journal:  J Neuroimmunol       Date:  2008-03-18       Impact factor: 3.478

7.  Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue.

Authors:  T Kawamata; H Akiyama; T Yamada; P L McGeer
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

Review 8.  Microglia in ALS: the good, the bad, and the resting.

Authors:  Jenny S Henkel; David R Beers; Weihua Zhao; Stanley H Appel
Journal:  J Neuroimmune Pharmacol       Date:  2009-12       Impact factor: 4.147

9.  Identification of HLA a*0201 glioblastoma multiforme cell lines for immunotherapy by PCR-SSP and DNA sequencing.

Authors:  An-Hua Wu; Walter A Hall; Walter C Low
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

10.  Robust ability of IFN-gamma to upregulate class II MHC antigen expression in tumor bearing rat brains.

Authors:  Tanya Dutta; Alexander Spence; Lois A Lampson
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.